CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

ViroCell Biologics and Great Ormond Street Hospital for Children Collaborate to Disrupt the Gene and Cell Therapy Industry

ViroCell Biologics and Great Ormond...

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

ViroCell Biologics and Great Ormond Street Hospital for Children Collaborate to Disrupt the Gene and Cell Therapy Industry

ViroCell Biologics and Great Ormond...

The several benefits Of Agricultural Genome Editing

Life Sciences Review | Tuesday, May 10, 2022
Tweet

Genome editing boosts crops' resistance to heat, floods, salinity, drought, and extreme cold.


FREMONT, CA: Genome editing can help boost a wide variety of crops that can resist heat, floods, salinity, drought, and extreme cold. Increasing yields while using low fertilizer, water, and nitrogen. Food waste reduction. Customers appreciate mushrooms, apples, and potatoes for their non-browning properties.


It is often easy for anti-technology, anti-corporate radicals to create their reality, particularly when it comes to the lucrative business of biotechnology fearmongering.


The following is the list of benefits of agricultural genome editing:


1. The low cost creates technology and ideas available to researchers in non-profit organizations, small businesses, and public institutions.


2. Precision breeding allows the exclusion of not-needed DNA through a speed breeding procedure.


3. limiting off-target mutations using site-specific editing approaches decrease the chance of adverse effects.


4. Reduced time required for breeding programs beacuse of decreased number of required plant generations.


5. Insect and pathogen stress tolerance helps plants to grow without pesticides. For instance, apples are resistant to fire blight; cassava is resistant to brown streak disease andmosaic virus, oranges are resistant to citrus greening disease, and potatoes are resistant to late blight.


6. Due to herbicide tolerance, farmers have advantages from more effective weed control for canola, rice, and flax.


7. Genome editing improves crops' resistance to heat, floods, salinity, extreme cold, and drought.


8. Increasing yields while implementing little fertilizer, water, and nitrogen.


9. Food waste reduction—customers appreciate mushrooms, apples, and potatoes for their non-browning characteristics.


10. Customers benefit from improved nutritional characteristics, like decreased acrylamide levels in potatoes, increased fiber levels in wheat, oleic oil content in soybeans, and better starch quality in corn.


11. Geographically focused research allows local scientists and research institutes to handle localized difficulties and challenges rather than huge corporations with global applications of singular qualities.


12. More feasible/affordable/immediate options are needed for critical animal research.


13. When vaccinations and selection have gone wrong, disease resistance by genome editing can affect safe animals from diseases such as RRS, BSE, or African swine fever.


14. More effective muscle development and body growth in animals result in increased financial benefits for producers.


15. Offspring selection eliminates the need to slaughter inefficient farm animals.


16. Improved conditions for animal welfare, including the development of hornless cows and reducing porcine heat loss.


17. Animals that have been genetically adjusted to effectively host human organ transplants (addressing the shortage of human tissues and organs).


18. Chances of decreasing antibiotic use in livestock while maintaining animal health


19. Decline in the registration of genetically modified (GM) plants, owing to the comparable costs and time required to comply with laws.


20. To meet society's demand, increasing yield for consistent food production while safeguarding the environment and reacting to climate change issues.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
Encouraging Innovation in Healthcare in a COVID - 19 World
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research

The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery

Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca
The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-several-benefits-of-agricultural-genome-editing-nwid-808.html